VRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years Old
Clinical trial NCT00973895 · COMPLETED
Trial details
- NCT number
- NCT00973895
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-06
- Primary completion
- 2010-09-03
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.